Role of intralesional polidocanol in management of Aneurysmal bone cyst.

Abstract

Background: Aneurysmal bone cyst is a true benign bone tumor often seen in young children and adolescents. ABCs often present with impending or pathological fracture due its aggressive cortical erosion. Modalities of treatment viz: Curettage with or without graft, Enbloc excision, cryotherapy, argon beam laser, radiotherapy, arterial embolization are often associated high morbidity & high complication rates. Objectives: The aim of this study was to evaluate the clinical & radiological efficacy of polidocanol in the management of Aneurysmal bone cyst. Material & Methods: After radiological and cytological confirmation of ABC, 18 patients meeting the inclusion criteria were included in this study. The patients were treated with intralesional polidocanol under fluoroscopic guidance. Results: The mean age of patients was 8.2 years. Mean number of injections required was 3.2, with three patients showing radiological resolution after single injection. Recurrence was seen in 1 patient after showing initial resolution. There were no cases of anaphylaxis or local inflammatory reactions. Conclusion: Polidocanol is a safe and inexpensive alternative to other modalities of treatment and should always be first line of treatment for the management of the Aneurysmal bone cyst.